Clinically Lymph Node Positive Prostate Cancer: At the Intersection of Focal and Systemic Disease Control.

Clinically Lymph Node Positive Prostate Cancer: At the Intersection of Focal and Systemic Disease Control. Cancer J. 2020 Jan/Feb;26(1):53-57 Authors: Reichert ZR, Dess RT Abstract Clinically node-positive prostate cancer is often found at the time of diagnosis by cross-sectional imaging and remains poorly understood. Advanced imaging modalities such as magnetic resonance imaging nanoparticles or positron emission tomography-based molecular imaging stand to rapidly change the field and hopefully will bring better diagnostic clarity. This will allow for prospective clinical trials using radiographic, clinical, or molecular parameters to establish who may benefit from both localized and systemic treatment intensification and who may avoid overtreatment. Recent advances in metastatic hormone-sensitive disease may offer clues, but direct studies for nodal disease patients remain. PMID: 31977386 [PubMed - in process]
Source: Cancer Journal - Category: Cancer & Oncology Authors: Tags: Cancer J Source Type: research